Trial met primary endpoint, non-inferior immune response for both vaccines when co-administered compared with separate ...

GSK plc GSK announced positive topline results from a phase III study evaluating the co-administration of its two marketed ...

Before the recalls, Zantac was sold by GSK, US pharma giant Pfizer, French drug company Sanofi and Boehringer Ingelheim, based in Germany. GSK said in a press release on Tuesday: "GSK welcomes ...

Shares of GSK PLC GSK inched down 0.97% to £16.39 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.57% to 8,240.97.

Drug maker GSK plc (GSK, GSK.L) confirmed Wednesday that it has reached two confidential settlements in cases filed in California ...

(Reuters) -British drugmaker GSK announced on Thursday positive results from a mid-stage trial of its seasonal influenza vaccine programme using the messenger RNA (mRNA) technology, and said it ...

(Reuters) -British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and ...

In the study, co-administration of GSK's RSV vaccine Arexvy and shingles shot Shingrix elicited non-inferior immune responses ...

GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new ...

British pharmaceutical group GSK on Friday (Aug 16) welcomed victory in drawn out US litigation regarding its Zantac drug for heartburn that allegedly caused cancer. The over-the-counter treatment, ...

The US Food and Drug Administration (FDA ... research and development at GSK, said: ‘Extensive-stage small-cell lung cancer is aggressive with poor prognosis and significant need for new ...